The biosynthesis of the secretory core gene product of the duck hepatitis B virus (DHBe protein) was examined. Recombinant vaccinia viruses were constructed encoding either the full-length or C-terminally truncated forms of the DHBe precursor protein (precore protein) and used to express these proteins in the human hepatoma cell line HepG2. Western immunoblot analysis of core gene products isolated from cells producing the full-length precore protein revealed the presence of DHBe precursor proteins containing the strongly basic C-terminal sequence which is lacking in the mature DHBe protein. These proteins were not secreted, suggesting that C-terminal proteolytic processing of the precore protein represents an obligatory step for DHBe biosynthesis. Pulse-chase experiments showed that this cleavage reaction occurs late during DHBe synthesis. Interestingly, when mutated precore proteins were expressed which lacked the basic C-terminal domain, proteins were produced which were glycosylated but not secreted. This shows that the transient presence of this region is essential for intracellular transport of the precore protein. Cell sorter analyses revealed that production of a cell surface-expressed variant of the secretory core protein is a feature conserved between the duck and the human hepatitis B viruses. Surprisingly, the C terminus of the membrane-expressed DHBe protein was accessible from the outside, showing that the topology of this interesting protein is more complicated than expected.
One feature of hepatitis B virus (HBV) gene expression is that at least two different core gene products are synthesized in infected cells (6) . One of these proteins, referred to as the c protein, is a cytoplasmic protein which has a strong tendency to aggregate. It forms the viral capsid and is exported from the cells only as part of a virus particle. In contrast, the other protein, referred to as the e protein, is a secretory protein which does not form aggregates. It can be detected in large amounts in the serum and serves as a serologic marker for diagnosis of an HBV infection. Why HBVs produce a secreted core gene product is unknown. This protein is not essential for the production of infectious virus (5, 22) ; however, it is speculated that it might possess immunomodulatory properties which could be important during the development of chronic infections (13) .
During the last few years, much has been learned about the mechanisms of c and e protein biosynthesis (7-9, 15, 16, 22, 25) (Fig. la) . The e protein is derived from a larger precursor (the precore protein) whose translation starts at an AUG that is located slightly upstream from the AUG where c protein translation initiates. For this reason, the precore protein contains a short N-terminal extra sequence which is lacking in the c protein. This portion, which is called the pre-C sequence, functions as a signal sequence and mediates the translocation of the precore protein into the endoplasmic reticulum (ER). During in vitro translation of HBV precore mRNA in the presence of microsomal membranes, most of the precore protein generated is N-terminally processed (7, 25) . Another proteolytic processing step occurring in vivo appears to be the removal of a strongly basic domain located at the C terminus of the precore protein, since this part is lacking in the secretory core protein which can be isolated from the serum of HBV-infected humans or ducks (22, 26) . Thus, the processed precore protein, which for historic reasons is also called the e protein (12) , differs from the c protein in that it contains a short extra sequence at its N terminus and lacks the basic domain at the C terminus.
Although the principles of c and e protein biosynthesis are now clear, there are still many open questions. For instance, the time points and the intracellular locations of the processing steps and their consequences for the different physical and serological properties of the c and e proteins are unclear. Moreover, as has been shown recently (23) , cells producing the HBV e protein also express a membrane-bound variant of this protein. How (21) . This fragment was then cloned into the HBVvaccinia virus construct HBc-VAC described previously (23) , from which all the HBV sequences except the HBV To investigate the relevance of the basic C-terminal domain of the DHBc for DHBe biosynthesis, mutants lacking the last 12, 36, or 89 amino acids were generated (Fig. ic) .
For construction of the 12-and 36-amino-acid deletion mutants, EcoRI-KpnI fragments were excised from two DHBc C terminus stop mutants described previously (19) and recloned into the DHBe-VAC construct. In these mutants, stop codons had been generated by single base exchanges at nucleotide positions 376 Freiburg, Germany). For background reduction, the immunoprecipitate thus obtained was boiled for 3 min in 50 ,ul of PBS-2% sodium dodecyl sulfate (SDS)-1% 2-mercaptoethanol and diluted 1:20 with PBS-1% Triton X-100. Insoluble material was again removed by centrifugation, and the immunoprecipitation step was repeated. After being washed with PBS, precipitated proteins were solubilized in sample buffer and separated on a 12.5% polyacrylamide gel. The gels were treated with En3Hance (Amersham-Buchler) and dried, and the isolated proteins were visualized by autoradiography at -70°C. Flow cytometry. Cells infected as described above were put on ice and incubated for 45 min on ice with either a polyclonal rabbit antiserum raised against denatured core protein or a polyclonal rabbit antipeptide serum specific for the last 13 C-terminal amino acids of DHBc, diluted 1:500 in Cellular radioimmunoassay. To further analyze the capacity of antisera to bind to the membrane-expressed DHBe, a cellular radioimmunoassay was used. Human hepatoma cells (HepG2 cells) were infected either with wild-type vaccinia virus or with the recombinants DHBc-VAC, DHBe-VAC, DHBe-VACA12, DHBe-VACA36, and DHBe-VACA89. At 10 to 14 h after infection, the cells were chilled on ice, washed with PBS, and incubated for 45 min on ice with the antisera described above for flow cytometry, diluted 1:500 in PBS-1% BSA-0. 1% sodium azide (1 ml of diluted antiserum per 10-cm2 dish). To remove unbound antibodies, the cells were washed once with PBS and incubated for 20 min with 2 ml of PBS-1% BSA-0.1% sodium azide on ice. Specifically bound antibody was detected by incubating the cells for 30 min with 0.5 ,uCi of 1251-labeled protein A (Amersham) in 0.7 ml of PBS-1% BSA-0. 1% sodium azide. Unbound protein A was removed by washing the cells with PBS and PBS-1% BSA-0.1% sodium azide as described above. The cells were then lysed in 1 ml of PBS with 1% Triton X-100, and bound radioactivity was determined in a gamma counter. Fig. 2 (left,  lane 1) , within the cells four proteins could be detected with apparent sizes of 27, 30, 32, and 34 kDa. Since the 30-and 34-kDa species were found to be glycosylated (see below), they are referred to as gp3oe and gp34e, respectively. The two other proteins will be referred to as p27e and p32e. Only p27e and gp3oe were secreted (Fig. 2, left, lane 2) . These proteins have the same size as the DHBe proteins which, as described previously (22) , can be isolated from the serum of infected ducks (Fig. 2, left, lane 3) . After digestion with endoglycosidase F, only p32e and p27e could be detected (Fig. 2, right) As shown in the left panel of Fig. 3 , the 12-amino-acid deletion had already shifted p32e and gp34e to smaller sizes, whereas p27e and gp3Oe were affected only after deletion of 89 amino acids. This shows that p32e and gp34c in fact represent C-terminally uncleaved precore proteins and that cleavage takes place either at or upstream of the position where the stop codon had been introduced in DHBe-VACA36. Moreover, the finding that p32e and gp34C were not secreted (compare lane 1 with lane 2 in Fig. 2 ) strongly suggests that C-terminal cleavage is an obligatory modification during DHBe biosynthesis.
Intracellular transport of a precore protein mutant lacking the last 89 C-terminal amino acids is blocked. Another interesting observation was made when tissue culture supernatants from cells infected either with DHBe-VAC or with viruses expressing the C-terminally truncated forms were examined for DHBe proteins. As shown in the center panel of Fig. 3 , the 12-and 36-amino-acid deletions did not interfere with DHBe secretion, a finding already observed in transient expression assays (19) . However, not even trace amounts of DHBe protein could be detected in the medium from cells producing the 89-amino-acid deletion variant, in spite of the fact that significant amounts of core gene products could be detected within the cells (Fig. 3, left  panel) . The same observation was made with several independent virus clones from different recombinations as well as with several variants in which the signal sequence had been altered (unpublished observation). Moreover, another mutant with a 137-amino-acid-long C-terminal deletion was also not secreted (unpublished observation). To test whether this defect in secretion was due to a block in translocation, core gene products from cells infected with the A89 mutant were subjected to endoglycosidase F digestion. As shown in the right panel of Fig. 3 , the intracellular protein was clearly glycosylated and therefore must have been translocated into the ER. Thus, the C-terminal deletion resulted in the production of a precore protein that was translocated but which was defective in intracellular transport.
C lysed in PBS with 1% Triton X-100, and core gene products were isolated by immunoprecipitation from the cell lysates and the culture medium and analyzed by SDS-PAGE with subsequent fluorography. As shown in the autoradiograph in the upper panel of Fig. 4 , the primary precore protein was the C-terminally uncleaved form. During the chase, this protein was gradually converted into mature e proteins. The first cleaved products could be observed after 45 min. Since at the same time the glycosylation pattern of the full-length protein became fuzzier, an observation indicating carbohydrate modification, this cleavage may occur during passage of the precore protein through the Golgi apparatus. After cleavage, export of the mature e protein occurred quite rapidly, since mature DHBe protein could already be detected in the 45-min medium sample (Fig.  4, lower panel) .
DHBe-producing cells express a membrane-bound DHBe protein. Recently, evidence has been provided that cells expressing the e protein of the human HBV also express a membrane-bound variant of this protein (23) . To test whether this property is shared by the duck and the human HBVs, HepG2 cells infected with DHBe-VAC were examined for cell surface-expressed DHBe proteins by flow cytometry. As controls, HepG2 cells were used which had been infected either with a vaccinia virus recombinant expressing the cytoplasmic core protein (DHBc-VAC; see Fig. lb) or with wild-type vaccinia virus. In the first experiment, the result of which is shown in the left part of Fig. 5 , cell surface-expressed core gene products were detected with a rabbit antiserum raised against denatured DHBc protein (anti-DHBc). This serum binds to both the DHBc and the DHBe. Apparently, the DHBe-VAC-infected cells were stained very strongly by this antiserum, whereas no significant reaction could be observed with the control cells. To obtain information about the topology of the membrane-bound DHBe protein, the cell sorter analysis was repeated with an antiserum raised against a peptide comprising the last 13 amino acids of the DHBV core protein (anti-DHBc CT [22] ). As is demonstrated in the right panels of Fig. 5 , this antiserum also bound strongly to the DHBeprodpcing cells, showing that the C terminus of this protein is accessible from the outside. In addition, since DHBe proteins containing this region are not secreted, this finding also provides a strong argument against the assumption that antibody binding might be due to adsorbed DHBe proteins.
To examine this point further, cellular radioimmunoassays were performed with cells infected either with wildtype vaccinia virus or with the recombinants DHBc-VAC, DHBe-VAC, DHBe-VACA&12, DHBe-VACA36, and DHBe-VACA89. As shown in Table 1 , in this assay the anti-DHBc serum also bound strongly to the DHBe-producing cells.
Deletion of the last 12 or 36 amino acids of the precore protein did not influence binding, showing that most of the basic C-terminal domain of the precore protein is dispensable for precore membrane expression. Since only a very weak reaction was observed with cells producing the 89-amino-acid deletion mutant, secretion appears to be essential for membrane transport.
The antipeptide serum also reacted with the DHBe-producing cells, a finding consistent with the observations made during the cell sorter analysis. Interestingly, this serum also reacted with the cells infected with the 12-amino-acid deletion mutant, that is, with cells producing a precore protein lacking 12 of the 13 amino acids against which this serum had been raised. Several independent analyses showed the same result. Inspection of the DHBV precore amino acid sequence then revealed that the C-terminal sequence of the full-length precore protein (last six amino acids, S-P-S-P-R-K) is very similar to the C-terminal sequence of the 12-amino-acid deletion mutant (last six amino acids, S-P-L-P-R-S). In fact, four of the last six amino acids are identical. Thus, it appears quite likely that the reactivity of the antipeptide serum with the cells producing the 12-amino-acid deletion mutant is due to this high degree of amino acid identity. In any case, deletion of the last 36 amino acids completely abolished reactivity with the antipeptide serum, whereas binding of the anti-DHBc serum was not affected. Therefore, at least part of the membrane-expressed precore protein must be arranged in such a way that the C-terminal sequence is extracytoplasmic.
DISCUSSION
Biosynthesis of the secretory core gene product of DHBV was examined by using recombinant vaccinia viruses. Compared with other methods which have been used previously for the study of HBV gene expression in tissue culture cells, this system has the advantage that protein quantities can be expressed that are large enough to detect biosynthetic intermediates. One possible drawback is that the influence of other viral proteins on precore processing can only be studied if the cells are infected with more than one recombinant. However, as has been shown in Fig. 2 , the DHBe protein synthesized by the DHBe-VAC-infected cells did not differ from the DHBe which can be isolated from duck sera.
Thus, it appears that other viral proteins are not important for precore processing. In particular, this finding demonstrates that the C-terminal cleavage of the precore protein either is autocatalytic or, as seems more likely, is mediated by a cellular protease.
When lysates from cells infected with a recombinant encoding the full-length precore protein were analyzed for core gene products, C-terminally uncleaved precore proteins could be readily detected. These proteins were located exclusively intracellularly. Thus, the uncleaved precore proteins either are actively retained within the cells or, alternatively, are not released. In fact, it appears possible that precore membrane expression is due to molecules which escaped from C-terminal processing.
Pulse-chase experiments showed that C-terminal proteolytic processing of the precore protein occurs relatively late during e protein biosynthesis. With respect to secretion efficiency, the DHBe protein behaved like a standard secretory protein. Secretion of pulse-labeled DHBe protein started about 45 min after labeling, and after 8 h, only small amounts remained within the cells. This is in contrast to findings reported for the HBV e antigen, suggesting that this protein is only poorly secreted (25) .
Interestingly, no secreted e proteins could be detected after expression of precore mutants which lacked the basic C-terminal domain. Since the intracellular forms were glycosylated, truncation did not affect the translocation of the precore protein into the ER but apparently blocked its intracellular transport. This finding was unexpected, since it is generally assumed that the C-terminal domain is only important for nucleocapsid production. Because of its high content of basic amino acids, it is believed that this region interacts with the packaged nucleic acid and thereby influences both core particle stability and genome replication. In fact, direct evidence supporting these assumptions has been provided recently for both DHBV and HBV (2, 19) . With respect to e protein biosynthesis, it was thought that this part of the precore protein was unimportant or even detrimental, because, as shown by in vitro translation experiments (3), it may represent an obstacle for the translocation process. It thus appeared reasonable that this domain had to be cleaved to allow e protein secretion. Yet, as is shown here, the C-terminal domain is by no means useless; rather, it is crucial for e protein production. What the exact role of this sequence is remains to be determined. Although it is possible that it is directly involved in the transport process, it appears more likely that it is needed for proper folding of the precore protein. As has been shown for several viral and cellular proteins, mutations can result in the production of aberrant proteins which, in their misfolded form, bind to certain resident ER proteins. As a consequence of this binding, these proteins are efficiently sorted back to the ER immediately after they have reached a specialized pre-Golgi compartment ("salvage compartment") whose function appears to be to prevent the export of improperly synthesized secretory proteins (17, 18) .
Recently, it has been found that HepG2 cells infected with a vaccinia virus recombinant encoding the e protein of human HBV produce a variant of this protein which is transported to the cell surface (23) . Most importantly, this cell surface-expressed HBV e protein is recognized by human antibodies whose appearance usually correlates with virus elimination (24). Thus, it appears possible that termination of HBV infection might be due at least in part to an antibody-mediated attack on the infected hepatocytes. Owing to the narrow host range of HBV, this hypothesis can hardly be tested with HBV; therefore, whether production of a cell surface-expressed e protein is a feature conserved between HBV and DHBV was examined. As shown here, this is in fact the case. HepG2 cells infected with DHBe-VAC showed a strong surface binding of DHBc-and e-specific antibodies, whereas DHBc-producing cells and control cells did not. Thus, the DHBV system is currently being used to examine the in vivo relevance of this interesting viral protein.
The mechanism by which the e protein is incorporated into the cell membrane is still unclear. To date, attempts to isolate the membrane-bound DHBe protein either directly or after cell surface iodination failed, most likely because of the scarcity of this protein (unpublished observations). However, in the case of HBV, development of an HBV e variant which expressed about 10-fold more of the membraneexpressed HBV e protein than the wild type allowed the detection of this protein, which appears to represent a C-terminally uncleaved precore protein (18a). That antibody binding is due to peptides which might be transported to the cell surface in association with histocompatibility antigens is unlikely, since cells infected with the secretion-deficient 89-amino-acid deletion mutant described here did not react with the antiserum. Thus, it appears that cell surface expression requires secretion. Moreover, the fact that the surfaceexpressed DHBe protein was efficiently recognized by the C-terminus-specific antipeptide serum strongly argues against the possibility that binding is due to adsorption of secreted e protein since, as shown here, DHBe variants containing this sequence were not secreted. This finding also raises questions about the topology of the membrane-bound e protein. As has been discussed above, from in vitro translation studies, it has been proposed that the basic C-terminal domain of the precore protein might represent an obstacle for ER translocation (3). This view, however, had already been challenged by the finding that transmembranous e proteins were not always observed after in vitro translation (7) . Moreover, as is shown here, deletion of most of the basic C-terminal domain of the DHBV precore protein did not influence e protein membrane expression. In addition, the fact that the C-terminal domain of the membranebound DHBe protein is accessible from the outside cannot be reconciled with a topology which requires this domain to be located within the cytoplasm.
